Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

BridgeBio Oncology slides as it tightens the scope of its KRAS program

BridgeBio Oncology Therapeutics' share price {$BBOT} plummeted by about 24% at market close Wednesday on the back of plans that it is scaling back its pipeline to focus on developing its lead KRAS inhibitor for ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

Liberia: The Long Wait for Fistula Surgery in Liberia

[Liberian Observer] This story was supported by the Pulitzer Center.

  • Lorpu suffered from obstetric fistula after difficult labor in 2020.
  • She underwent three unsuccessful local treatments for the condition.
  • Lorpu spent over $914 on seeking surgery during free treatment campaign.

More from Thursday 10 September →